Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHARE: Epzicom and Reyataz Maintenance in HIV-1
NCT00426296Phase 4Unknown
- Sponsor
- The Clinical Alliance for Research and Education - Infectious Diseases
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abacavir + lamivudine, atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by The Clinical Alliance for Research and Education - Infectious Diseases. Status: unknown.
02
Drugs
abacavir + lamivudineatazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00426296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426296.